News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cost Cuts Help Actelion Ltd. (ALIOF.PK) Lift Earnings View



7/19/2012 6:46:47 AM

Actelion Ltd. (ATLN), the Swiss maker of the Tracleer blood-pressure drug, climbed the most in two weeks after the company raised its profit forecast for 2012 on reduced spending and second-quarter revenue that beat estimates. The shares advanced as much as 3 percent to 42.50 Swiss francs, the biggest intraday gain since July 5, and were up 2.7 percent at 42.36 francs as of 9:29 a.m. in Zurich. Core earnings, or sales minus cash operating expenses and excluding currency effects, will rise in a “mid single-digit” percentage range, Allschwil-based Actelion said in a statement today. The drugmaker had expected earnings to remain unchanged from 2011 figures. The company reiterated that sales will probably fall by a low single-digit percentage.

Read at BusinessWeek
Read at Reuters
Read at RTT News


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES